<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4939">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02007902</url>
  </required_header>
  <id_info>
    <org_study_id>2013/CHU/02</org_study_id>
    <secondary_id>2013-A00090-45</secondary_id>
    <nct_id>NCT02007902</nct_id>
  </id_info>
  <brief_title>Plasma Protein Levels and Very Preterm Birth</brief_title>
  <acronym>ProHémie</acronym>
  <official_title>Early Plasma Protein Levels and Neonatal Hemodynamics: a Prospective Evaluation in Very Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de la Réunion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>INSERM CIE1, Dijon, F-21000, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de la Réunion</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to investigate the relationship between early plasma
      protein levels and hemodynamics in very preterm infants during postnatal transition.
      Secondary aims are the following: i) to evaluate maternal and neonatal factors affecting
      plasma protein level at birth; ii) to evaluate the relationship between plasma protein level
      and albumin level on the first day of life; iii) to evaluate the association between early
      hypoproteinemia and neonatal mortality and morbidity in very preterm infants.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Evidence of clinical hemodynamic disturbances defined by arterial hypotension (non-invasive measure of MAP - mmHg - pathological for gestational age) or measured at organ colour doppler, echocardiography or NIRS</measure>
    <time_frame>about 6 hours after birth</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma protein</measure>
    <time_frame>at 1 second after birth (cord blood sample)</time_frame>
    <safety_issue>No</safety_issue>
    <description>plasma protein level on cord blood sample depending on maternal and neonatal variables</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin level</measure>
    <time_frame>At 12 hours after birth</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>patients will be followed for the duration of hospital stay, that is an average of 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Very Preterm Infants</condition>
  <arm_group>
    <arm_group_label>Very preterm babies</arm_group_label>
    <description>Observational model: cohort</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluation of the relationship  plasma protein levels - neonatal hemodynamics</intervention_name>
    <description>Patient inclusion at birth
Total plasma protein values measurement on cord blood sample at birth
Hemodynamic evaluation at 6 hours after birth with colour doppler echocardiography and organ blood flow colour doppler
Total plasma protein and albumin values measurement on plasma sample at 12 hours after birth
Blood pressure, heart rate, O2 saturation, capillary refill time, rSO2 [regional (cerebral and somatic) tissue oxygenation by NIRS - near infrared spectroscopy] will be monitored over 24 hours after birth.</description>
    <arm_group_label>Very preterm babies</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Very preterm infants with birth at less than 32 weeks of gestational age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parents written informed consent

          -  Birth at less than 32 weeks of gestational age

          -  Birth in a III level delivery facility at Reunion Island

        Exclusion Criteria:

          -  Major congenital abnormalities
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Hour</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia Iacobelli</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de La Réunion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Iacobelli</last_name>
    <phone>0262 35 95 78</phone>
    <email>silvia.iacobelli@chu-reunion.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samir Medjane</last_name>
    <phone>02 62 90 62 86</phone>
    <email>samir.medjane@chu-reunion.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hopsitalier Universitaire de La Réunion</name>
      <address>
        <city>Saint Denis</city>
        <state>La Réunion</state>
        <zip>97405</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sylvain Samperiz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Duksha Ramful</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de La Réunion</name>
      <address>
        <city>Saint Pierre</city>
        <state>La Réunion</state>
        <zip>97448</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Silvia Iacobelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Bonsante</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preterm baby</keyword>
  <keyword>Total plasma protein</keyword>
  <keyword>Albumin</keyword>
  <keyword>Hemodynamic disturbances</keyword>
  <keyword>Perfusion</keyword>
  <keyword>Near Infra Red Spectroscopy (NIRS)</keyword>
  <keyword>Ultrasound</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
